Tag: sars
Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study
16.02.2021
 
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report
08.02.2021
 
Neurological Adverse Events Emerging in Covid-19 Vaccine Trial. Is Autoimmunity Involved?
08.02.2021
 
Sarcoidosis, a systemic granulomatous disease of unknown etiology, may mimic other conditions at presentation often resulting in delayed diagnosis.These conditions include infections, neoplasms, autoimmune, cardiovascular, and drug-induced diseases. This review highlights the most common sarcoidosis mimics that often lead to pitfalls in diagnosis and delay in appropriate treatment. Prior to invasive testing and initiating immunosuppressants (commonly corticosteroids), it is important to exclude sarcoid mimickers.
01.02.2021
 
Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: A meta-analysis of observational studies
21.01.2021
 
SARS-CoV-2, the autoimmune virus
21.01.2021
 
Diverse Functional Autoantibodies in Patients with COVID-19
21.01.2021
 
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
21.01.2021
 
More than a year after COVID-19 emerged, many mysteries persist about the disease: why do some people get so much sicker than others? Why does lung damage sometimes continue to worsen well after the body seems to have cleared the SARS-CoV-2 virus? And what is behind the extended, multi-organ illness that lasts for months in people with ‘long COVID’? A growing number of studies suggest that some of these questions might be explained by the immune system mistakenly turning against the body — a phenomenon known as autoimmunity.
21.01.2021
 
Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis
11.01.2021